Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →
ARTV · $50K+ · 105 trades
Trades
105
Buys 96 · Sells 9
People
10
Stocks
1
Disclosed value
$108M
range midpoints · Congress & executive
Filed late
0
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$70.5Kdisclosed Jul 20 · filed 3 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$70.5Kdisclosed Jul 20 · filed 3 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$70.5Kdisclosed Jul 20 · filed 3 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$70.5Kdisclosed Jul 20 · filed 3 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$1.4Mdisclosed Jul 20 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$58.6Kdisclosed Jul 14 · filed 1 day after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$135Kdisclosed Jul 14 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade
- ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade
- ▲ BUYRA Capital Nexus Fund III, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade
- ▲ BUYRa Capital Management, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade
- ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade
- ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$275Kdisclosed Jun 29 · filed 4 days after the trade